List of diagnostic benefits grows for eye tests.
Add Alzheimer’s disease to the long list of chronic conditions for which eye tests may be a diagnostic aid. A clinical trial of Sapphire II, an eye-testing system from Enanta Pharmaceuticals designed to detect Alzheimer’s in non-symptomatic patients, has been deemed a success, according to research reported last month in the “Journal of Alzheimer's Disease & Other Dementias.” Meanwhile, a study by UnitedHealthcare showed that eye care professionals are instrumental in early diagnosis of a range of conditions, including diabetes, multiple sclerosis, high cholesterol and hypertension, rheumatoid arthritis, juvenile rheumatoid arthritis, Crohn’s disease and Graves disease.
Hear What the Industry Thinks About the Ultimate Lens Package by Essilor
Eye care professionals, patients, and Essilor sales consultants shared their feedback on the Ultimate Lens Package. Watch to see why they believe the innovation behind the lens can make the difference for your practice and for your patients. For more information on the Ultimate Lens Package, contact an Essilor Sales Consultant or click here.